EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer

Hua Su, Chao Peng, Yang Liu

Frontiers in Cell and Developmental Biology · 18.03.2024 · 12

DOI: 10.3389/fcell.2024.1372330 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 18.03.2024. Verfasst von Hua Su und 2 weiteren Autor:innen. Beteiligte Einrichtung: Xingyi People's Hospital, Xinyi, China. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global challenge posed by cancer, marked by rising incidence and mortality rates, underscores the urgency for innovative therapeutic approaches. The PI3K/Akt signaling pathway, frequently amplified in various cancers, is central in regulating essential cellular processes. Its dysregulation, often stemming from genetic mutations, significantly contributes to cancer initiation, progression, and resistance to therapy. Concurrently, ferroptosis, a recently discovered form of regulated cell death characterized by iron-dependent processes and lipid reactive oxygen species buildup, holds implications for diseases, including cancer. Exploring the interplay between the dysregulated PI3K/Akt pathway and ferroptosis unveils potential insights into the molecular mechanisms driving or inhibiting ferroptotic processes in cancer cells. Evidence suggests that inhibiting the PI3K/Akt pathway may sensitize cancer cells to ferroptosis induction, offering a promising strategy to overcome drug resistance. This review aims to provide a comprehensive exploration of this interplay, shedding light on the potential for disrupting the PI3K/Akt pathway to enhance ferroptosis as an alternative route for inducing cell death and improving cancer treatment outcomes.

Schlagwörter

Stichwörter der Autor:innen

AktPI3KPI3K/AKTcancercell deathferroptosis

Autor:innen und Institutionen

  • Xingyi People's Hospital, Xinyi, China.
  • The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Zitieren

APA

Su, H., Peng, C., & Liu, Y. (2024). Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1372330

Vancouver

Su H, Peng C, Liu Y. Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1372330

BibTeX
@article{Su2024,
  author = {Su, Hua and Peng, Chao and Liu, Yang},
  title = {Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fcell.2024.1372330}
}
Kostenlos starten →